This edition of the Research Video Series looks at the HD Buzz article, discussing a CRISPR-based approach called “base editing”. This is being explored to develop a new potential treatment for Huntington's disease.
Research Video Series Sponsors: Roche, Sage Therapeutics, Teva Pharmaceuticals, uniQure, Wave Life Sciences, Neurocrine Biosciences and the Griffin Foundation.